![James Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 698 291 $ in data 31/05/2026
James Brady is an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. since 2025.
Former roles include Director at Panavance Therapeutics, Inc. from 2021 to 2025, Independent Non-Executive Director at Verona Pharma Ltd. from 2022 to 2025, Chief Financial Officer at MedImmune Ltd. from 2013 to 2018, and Chief Audit Executive at AstraZeneca PLC from 2009 to 2012.
Education includes an MBA from Drexel University and an undergraduate degree from St. Joseph University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 113.359 ( 0,07% ) | 698 291 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direttore/Membro del Consiglio | 28/03/2025 |
| Società | Posizione | Fine |
|---|---|---|
| VERONA PHARMA PLC | Direttore/Membro del Consiglio | 07/10/2025 |
Panavance Therapeutics, Inc.
 Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direttore/Membro del Consiglio | 01/02/2025 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Direttore Finanziario/CFO | 01/01/2018 |
| ASTRAZENECA PLC | Comptroller/Controller/Auditor | 01/01/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology Engages in research and development of human monoclonal antibodies | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
St. Joseph University
 St. Joseph University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Panavance Therapeutics, Inc.
Panavance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
